Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.1M Buy
66,556
+56,494
+561% +$2.61M 0.95% 21
2026
Q1
$493K Buy
+10,062
New +$468K 0.24% 91
2025
Q4
– Sell
-15,582
Closed -$701K – 188
2025
Q3
$701K Sell
15,582
-26,857
-63% -$1.18M 0.26% 130
2025
Q2
$1.84M Buy
+42,439
New +$1.89M 0.69% 42
2025
Q1
– Sell
-8
Closed -$301 – 129
2024
Q4
$301 Buy
+8
New +$310 ﹤0.01% 253

Other funds holding EXC

Stance Capital's EXC Position: Q2 2026 in Review

Stance Capital increased its Exelon (EXC) stake by 561% in Q2 2026, buying an estimated $2.61M and bringing the position to 66,556 shares worth $3.1M. The position accounts for 0.95% of the portfolio, ranked #21.

Stance Capital first reported a position in EXC in Q4 2024 and has held it in 5 quarters since. 1,292 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Stance Capital held 66,556 shares of Exelon worth $3.1M as of Q2 2026.
  • Stance Capital bought 56,494 Exelon shares in Q2 2026, an estimated $2.61M.
  • Exelon made up 0.95% of Stance Capital's portfolio in Q2 2026, its #21 holding.
  • Stance Capital first reported a position in Exelon in Q4 2024 and has held it in 5 quarters since.
  • 1,292 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.